Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.34 |
| ▸ | RORC | P51449 | 1/20 | 0.34 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.33 |
| ▸ | PLA2G5 | P39877 | 2/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.32 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 2/20 | 0.31 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.31 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.30 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.30 |
| ▸ | WNT1 | P04628 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14671153 | 0.80 | RORC (0.35) | RORCPLA2G10PLA2G5DRD2CYP4F2 | |
| SCHEMBL31531412 | 0.79 | PLA2G10 (0.39) | RORCPLA2G10PLA2G5DRD2CACNA1H | |
| SCHEMBL28509736 | 0.78 | DRD2 (0.36) | RORCPLA2G10PLA2G5DRD2CACNA1H | |
| SCHEMBL18063233 | 0.77 | RORC (0.34) | RORCPLA2G10PLA2G5CYP4F2CYP4A11 | |
| SCHEMBL13092962 | 0.75 | RORC (0.35) | RORCPLA2G10PLA2G5DRD2CYP4F2 | |
| SCHEMBL20631256 | 0.74 | PLA2G10 (0.38) | RORCPLA2G10PLA2G5DRD2CACNA1H | |
| SCHEMBL3799622 | 0.74 | PLA2G10 (0.41) | PLA2G10PLA2G5CACNA1HWNT1GSK3B | |
| SCHEMBL3470166 | 0.74 | PLA2G10 (0.41) | PLA2G10PLA2G5CACNA1HWNT1GSK3B | |
| SCHEMBL27147241 | 0.74 | PLA2G10 (0.41) | PLA2G10PLA2G5CACNA1HWNT1GSK3B | |
| SCHEMBL25728385 | 0.74 | HSD17B10 (0.37) | PLA2G10PLA2G5CACNA1H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230271917-A1 | AMINO ACIDS | PARABILIS MEDICINES, INC. | 2023-08-31 | — | — | US | disclosed |
| WO-2022261257-A1 | STAPLED PEPTIDES AND METHODS THEREOF | FOG PHARMACEUTICALS, INC. (US) | 2022-12-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230271917-A1 | AMINO ACIDS | NPPA, QPCTL, PTMS | FFAR3 3058/4885RORC 3965/4885PLA2G10 1483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.